NCT04750785View on ClinicalTrials.gov

A Study to Assess Choroideremia (CHM) Health Outcomes

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

September 27, 2021

Study Completion Date

September 27, 2021

Conditions
Choroideremia
Interventions
OTHER

No Intervention

Administered as specified in the treatment arm.

Trial Locations (8)

15213

Research Site, Pittsburgh

32607

Research Site, Gainesville

33146

Research Site, Coral Gables

53705

Research Site, Madison

90095

Research Site, Los Angeles

94158

Research Site, San Francisco

97239

Research Site, Portland

Research Site, Dallas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT04750785 - A Study to Assess Choroideremia (CHM) Health Outcomes | Biotech Hunter | Biotech Hunter